These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2249429)

  • 41. Combined model for diabetes lifestyle support.
    Gyuk P; Szabo I; Vassanyi I; Kosa I; Kovacs L
    Stud Health Technol Inform; 2014; 197():77-81. PubMed ID: 24743081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An intelligent diabetes software prototype: predicting blood glucose levels and recommending regimen changes.
    Otto E; Semotok C; Andrysek J; Basir O
    Diabetes Technol Ther; 2000; 2(4):569-76. PubMed ID: 11469620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Web-based system for the intelligent management of diabetic patients.
    Riva A; Bellazzi R; Stefanelli M
    MD Comput; 1997; 14(5):360-4. PubMed ID: 9308344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Technological advancements in diabetes care.
    Christiano AS; Shessler EM
    Adolesc Med State Art Rev; 2010 Apr; 21(1):129-37, x. PubMed ID: 20568560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.
    Lecomte P; Foubert L; Coddens J; Dewulf B; Nobels F; Casselman F; Cammu G
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):937-42. PubMed ID: 21640613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic literature review of use of blood glucose monitoring in phase III clinical studies of insulin analogs.
    Miikkulainen K; Caruso A; Mast O; Zhang R; Borisenko O
    BMC Endocr Disord; 2016 May; 16(1):21. PubMed ID: 27145817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modeling the physiological glucose-insulin dynamic system on diabetics.
    Chen CL; Tsai HW; Wong SS
    J Theor Biol; 2010 Aug; 265(3):314-22. PubMed ID: 20466007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
    Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
    Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Will computers replace or complement the diabetes educator?
    Hauser T; Chisholm DJ
    Med J Aust; 1992 Oct; 157(7):489-91. PubMed ID: 1406401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.
    Galic E; Vrtovec M; Bozikov V; Schwarzenhofer M; Milicevic Z
    Med Sci Monit; 2005 Dec; 11(12):PI87-92. PubMed ID: 16319804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of different generations of computer algorithms on diabetes control.
    Beyer J; Schrezenmeir J; Schulz G; Strack T; Küstner E; Schulz G
    Comput Methods Programs Biomed; 1990; 32(3-4):225-32. PubMed ID: 2249421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimum insulin use in older diabetics.
    Shuman CR
    Geriatrics; 1984 Oct; 39(10):71-4, 79-84, 89. PubMed ID: 6383955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basal-bolus insulin therapy in Type 1 diabetes: comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin.
    Herz M; Arora V; Sun B; Ferguson SC; Bolli GB; Frier BM
    Diabet Med; 2002 Nov; 19(11):917-23. PubMed ID: 12421428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
    Tang F; Wang Y
    J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microcomputer-aided insulin dose determination in intensified conventional insulin therapy.
    Shimauchi T; Kugai N; Nagata N; Takatani O
    IEEE Trans Biomed Eng; 1988 Feb; 35(2):167-71. PubMed ID: 3280463
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
    Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
    Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
    Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AIDA: an automated insulin dosage advisor.
    Lehmann ED; Deutsch T
    Proc Annu Symp Comput Appl Med Care; 1992; ():818-9. PubMed ID: 1482998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Important points and problems in insulin therapy of diabetes mellitus].
    Shichiri M
    Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):395-9. PubMed ID: 7751776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.